pharma manufacturing news

Showing 15 posts of 62 posts found.

Lonza buys Arch Chemicals for $1.2 billion

July 12, 2011
Manufacturing and Production Lonza, pharma manufacturing news

Swiss fine chemical and contract manufacturing company Lonza has agreed to buy Arch Chemicals of the USA for $1.2 billion …

Cadila plant in India gets FDA warning

July 11, 2011
Manufacturing and Production Cadila, FDA warning letter, pharma manufacturing news

Indian drugmaker Cadila Healthcare has been taken to task by the US FDA for quality violations at a new sterile …

Merck & Co

Merck to close one facility, boosts another

July 5, 2011
Manufacturing and Production, Research and Development Ireland, Merck & Co, pharma job cuts, pharma manufacturing news

Merck & Co continues to shake up its network of facilities, deciding to close a recently-acquired site in the USA …

Pfizer re-acquires Rouses Point from Akrimax

July 5, 2011
Manufacturing and Production Pfizer, pharma manufacturing news

Pfizer has decided to buy back a manufacturing facility in Rouses Point, New York, from current owner Akrimax Pharmaceuticals, and …

US team make human ‘biocollagen’ in plants

July 5, 2011
Manufacturing and Production collegen, cosmetic surgery, manufacturing and production news, pharma manufacturing news

A team of researchers in the USA have successfully synthesised human collagen in transgenic maize seeds, offering a potential alternative …

Grindeks opens API plant in Latvia

June 30, 2011
Manufacturing and Production Grindeks, pharma manufacturing news

Latvian pharmaceutical company Grindeks has opened a new active pharmaceutical ingredient (API) manufacturing plant that it predicts will add around …

Shire gets green light for second Replagal facility

June 28, 2011
Manufacturing and Production Replagal, Shire, Vpriv, pharma manufacturing news

The European Medicines Agency has approved a second manufacturing facility in the USA for Shire’s Fabry disease treatment Replagal. Shire’s …

GlaxoSmithKline fined $41m for manufacturing failings

June 28, 2011
Manufacturing and Production GSK, pharma manufacturing news

GlaxoSmithKline has agreed to pay almost $41 million to dozens of US states in a lawsuit focusing on alleged substandard …

Pharma manufacturing news in brief

June 28, 2011
Manufacturing and Production pharma manufacturing news

Abbott delays closure of Canadian facility, West Pharma starts a new build in China, plus updates from Vetter, Pharmadule and …

Pfizer sells Irish manufacturing facility to BioMarin

June 27, 2011
Manufacturing and Production BioMarin, Ireland, Pfizer, pharma manufacturing news

Pfizer is selling its Irish manufacturing facility in Shanbally, Cork, to US biopharmaceutical company BioMarin for $48.5 million, creating up …

Novo Nordisk

Novo Nordisk invests €134m in Danish facility

June 24, 2011
Manufacturing and Production Novo Nordisk, biologics, pharma manufacturing news

Novo Nordisk plans to invest almost 1 billion Danish kroner (134 million euros) in a new biologics manufacturing facility at …

Pfizer project is quality-by-design milestone for FDA and EMA

June 21, 2011
Manufacturing and Production EMA, FDA, Quality by Design, pharma manufacturing news

A pilot project set up earlier this year to encourage the adoption of quality-by-design in pharmaceutical manufacturing has passed its …

Novartis breaks ground on $500m Russian facility

June 21, 2011
Manufacturing and Production Novartis, Russia, pharma manufacturing news

Novartis has started construction of its new pharmaceutical manufacturing plant in St. Petersburg, Russia.The company has broken ground on the …

Dr Reddy’s API plant in Mexico under FDA scrutiny

June 21, 2011
Manufacturing and Production APIs, Dr Reddy's, FDA, GMP violations, pharma manufacturing news

Indian drugmaker Dr Reddy’s Laboratories has been sent a warning letter by the US FDA after a manufacturing facility in …

Smelly Risperdal adds to J&J’s recall tally

June 20, 2011
Manufacturing and Production John Lechleiter, pharma manufacturing news, recalls

Johnson & Johnson continues to be plagued by product recalls, with the latest involving two lots of its schizophrenia drug …

Latest content